Merck Strikes Back In Fosamax Case
As new suits continue to pour into the courts, Merck & Co. has formally shot back in its multidistrict, product liability war over Fosamax, denying all allegations lodged against the osteoporosis...To view the full article, register now.
Already a subscriber? Click here to view full article